References
- Akaike H. An information criterion (AIC). Mathematical Scientist App. Prob. Trust 1976; 14: 5–11
- Donatelli P., Marchi G., Giuliani L., Gustafsson L. L., Pacifici G. M. Stereo-selective inhibition by chloroquine of histamine N-methyltransferase in the human liver and brain. European Journal of Clinical Pharmacology 1994; 47: 345–349
- Dunchin K. L., McKinstry D. N., Cohen A. I., Migdalof B. H. Pharmacokinetics of captopril in healthy subjects and in patients with cardiovascular diseases. Clinical Pharmaco-kinetics 1988; 14: 241–259
- Dunchin K. L., Singhvi S. M., Willard D. A., Migdalof B. H., McKinstry D. N. Captopril kinetics. Clinical Pharmacology and Therapeutics 1982; 31: 452–458
- Ferroni M. A., Marchi G., Sansone E., Romeo P., Giulianotti P. C., Pietrabissa A., Mosca F., Pacifici G. M. Variability in the rate of 6-mercaptopurine methylation in the erythrocytes, liver and kidney of an Italian population. European Journal of Clinical Pharmacology 1996, in press
- Francis G., Goldsmith S. R. Treatment of cardiovascular disorders: congestive heart failure. Clinical Pharmacology, 3rd edn, K. L. Melmon, H. F. Morelli, B. B. Hoffman, D. W. Nierenberg. McGraw-Hill, New York 1992; 124–125
- Garrison J. C., Peach M. J. Renin and angiotensin. The Pharmacological Basis of Therapeutics, 8th edn, A. Goodman Gilman, T. W. Rall, A. S. Nies, P. Taylor. McGraw-Hill, New York 1992; 749–763
- Glauser T. A., Kerremans A. L., Weinshilboum R. M. Human hepatic microsomal thiol methyltransferase. Drug Metabolism and Disposition 1992; 20: 247–255
- Keith R. C., Jardine I., Kerremans A., Weinshilboum R. M. Human erythrocyte membrane thiol methyltransferase. Drug Metabolism and Disposition 1984; 12: 717–724
- Keith R. A., Van Loon J., Wussow L. F., Weinshilboum R. M. Thiol methylation pharmacogenetics: heritability of human erythrocyte thiol methyltransferase activity. Clinical Pharmacology and Therapeutics 1983; 34: 521–528
- Lowry O. H., Rosebrough N. J., Farr A., Randall R. J. Protein measurement with Folin phenol reagent. Journal of Biological Chemistry 1951; 193: 265–275
- Mentrè F., Gomeni R. A two-step iterative algorithm for estimation in non-linear mixed-effect models with an evaluation in population pharmacokinetics. Journal of Biopharmaceutical Statistics 1995; 5: 141–148
- Pacifici G. M., Fracchia G. N. Human methyltransferases. Classification and metabolic profile of the major isoforms. The point of view of the clinical pharmacologist. Advances in Drug Metabolism in Man, G. M. Pacifici, G. N. Fracchia. European Commission, Luxembourg/Brussels 1995; 461–493
- Pacifici G. M., Romiti P., Santerini S., Giuliani L. S-methyltransferases in human intestine: differential distribution of the microsomal thiol methyltransferases and cytosolic thiopurine methyltransferase along the human bowel. Xenobiotica 1993; 23: 671–679
- Pacifici G. M., Santerini S., Giuliani L. Methylation of captopril in human liver, kidney and intestine. Xenobiotica 1991; 9: 1107–1112
- Pond S. M., Tozer T. N. First-pass elimination basic concepts and clinical consequences. Clinical Pharmacokinetics 1984; 9: 1–25
- Price R. A. P., Keith R. A., Spielman R. S., Weinshilboum R. M. Major gene polymorphism for human erythrocyte (RBC) thiol methyltransferase (TMT). Genetic Polymorphism 1989; 6: 651–662
- Thind G. S. Angiotensin converting enzymes inhibitors: comparative structure, pharmacokinetics and pharmacodynamics. Cardiovascular Drug and Therapy 1990; 4: 199–206